The Adverse Events in FDAs Review Three FAERS reports were discussed FDAs briefing describes reports in its Adverse Event Reporting System involving an injection-site reaction, shortness of breath, diffuse skin darkening, and gum darkening
What This Means for Employers If your plan uses Express Scripts, you should expect meaningful changes to how formularies are designed, how drugs are priced, how reporting is provided, and the fee structure starting in 2028
(PubMed) Talebian A, Soltani B, Banafshe HR, Moosavi GA, Talebian M, Soltani S
As more and more people took the drugs, stories spread about food noise, and researchers started looking even more closely at what was going on in the brain
Given their clinical benefits and high price tags, GLP-1 RAs exemplify a tension in drug coverage: broad therapeutic value versus cost-containment